tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Income Statement

Compare
567 Followers

Tenax Therapeutics Income Statement

Last quarter (Q3 2024), Tenax Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tenax Therapeutics's net income was $-3.96M. See Tenax Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -7.57K$ -113.33K$ -108.98K$ -114.75K$ -107.28K
Operating Expenses
$ 8.23M$ 11.05M$ 32.73M$ 9.87M$ 8.56M
Depreciation and Amortization
$ 7.57K$ 113.33K$ 108.98K$ 114.75K$ 107.28K
EBITDA
-$ -10.93M$ -32.36M$ -9.74M$ -8.29M
Operating Income
-$ -11.05M$ -32.73M$ -9.87M$ -8.56M
Other Income/Expenses
$ 523.27K$ 4.75K$ 253.88K$ 16.54K$ 160.90K
Pretax Income
$ -7.71M$ -11.05M$ -32.47M$ -9.85M$ -8.39M
Net Income
$ -7.71M$ -11.04M$ -32.73M$ -9.87M$ -8.39M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -31.09$ -600.46$ -2.55K$ -1.52K$ -27.10
Diluted EPS
$ -31.04$ -600.46$ -2.55K$ -1.52K$ -27.10
Weighted Average Shares Outstanding
248.00K 18.39K 12.86K 6.48K 309.77K
Weighted Average Shares Outstanding (Diluted)
248.45K 18.39K 12.86K 6.48K 309.77K
Currency in USD

Tenax Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis